品牌名称：

型号规格：

批准文号： 仅供科研使用

产品标签：

产品卖点：

销售渠道：医院

025-86978335

产品介绍：

【产品名称】

通用名称：瘦素检测试剂盒（酶联免疫法）

英文名称：Leptin ELISA

【预期用途】

用于定量检测人血清或血浆中瘦素。仅供科研使用。不用于临床诊断。

【包装规格】

96T/盒

【背景知识】

1994 年，蛋白激素瘦素被鉴定为 ob 基因 (1,2) 的产物，其分子量为 16 kD，被认为在体重调节中起关键作用。其氨基酸序列与其他蛋白质没有主要同源性 (1)。瘦素几乎完全由分化的脂肪细胞产生 (3-5)。它作用于中枢神经系统，尤其是下丘脑，抑制食物摄入并增加能量消耗 (2,6-9)。存在不同剪接形式的瘦素受体，长度不同，它们属于细胞因子 1 类受体家族 (10-12)，在体内无处不在 (10,11,

13,14)。这表明瘦素的综合功能尚未完全了解。

许多瘦素结合蛋白中的一种代表瘦素受体的循环形式 (15)。

除了对新陈代谢的影响外，瘦素还对许多内分泌轴有很强的影响。在雄性小鼠中，它分别减弱了饥饿引起的 LH、睾酮和甲状腺素的显着下降以及 ACTH 和皮质酮的增加。在雌性小鼠中，瘦素可防止饥饿引起的排卵延迟 (16)。由于 ob 基因突变而缺乏瘦素的 Oblob 小鼠是不育的。这种缺陷可以通过瘦素应用来纠正，但不能通过禁食导致的体重减轻来纠正 (17)。这表明瘦素在生殖中起着重要作用。

瘦素的作用至少可以部分解释为瘦素对弓形核神经元形成和分泌神经肽 Y (NPY) 的抑制作用 (6,18,19)。NPY 是一种有效的食欲刺激剂 (20 ,21) 并且已知参与调节各种垂体激素。例如，这些包括通过刺激生长抑素来抑制生长激素 (22,23)、抑制促性腺激素 (23) 和刺激垂体-肾上腺轴 (21)。

决定循环瘦素浓度的最重要变量是体脂肪量 (24-26)。在定期进食的情况下，瘦素反映了脂肪组织的百分比 (27)。瘦素浓度随脂肪量呈指数增加。瘦素的这种组成合成受多种非激素和激素因素的调节。啮齿动物和人类的刺激物是暴饮暴食 (28,29)、胰岛素 (3,5,30-33) 和糖皮质激素 (5,34-36)。

一般来说，瘦素是各种代谢和内分泌反馈回路的重要组成部分。

对于临床使用，重要的是要注意瘦素水平显示出适度的昼夜节律变化，在凌晨 2 点左右达到峰值 (37)。此时的瘦素水平大约比早上或下午早些时候测量的水平高 30-100%。随着食物摄入量，在抽取血样时必须考虑这些波动。在标准化条件下，例如正常的饮食节奏和早上或下午早些时候的采血，瘦素测量足以提供信息性陈述。

需要参考范围才能对测量的瘦素值进行有意义的解释。由于体重对数值的影响最大，所以参考范围应与体脂量（Body Mass Index，BML，或体脂百分比，由 Bioelectrical Impedance Estimation，BIA 确定）相关。瘦素水平存在年龄依赖性 (38)。此外，对于相同的脂肪量，女性的瘦素水平高于男性 (39,40)。因此，参考范围还应考虑性别和青春期发育。

肥胖人群中常见的高水平瘦素表明瘦素不敏感（20,26,37,38,41,42）。然而，在少数患者中发现瘦素水平相对于体脂肪量不成比例地低。需要进一步的研究来证明这些患者代表了一种新的病理生理状况：瘦素缺乏症。由于瘦素对生殖功能非常重要，因此可能会发现将不孕症与瘦素产生不足联系起来的新病理生理机制。

如果饮食节奏正常，在早上或下午早些时候采集一次血样就足够了。

参考文献：

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM.1994 Positional cloning of themouse obese gene and its human homologue. Nature.372:425-432.

2. Halaas JL, Gajiwala KS,Maffei M, et al.1995 Weight-reducing effects of the plasma protein encoded bythe obese gene.Science. 269:543-546.

3. MacDougald OA, Hwang CS,Fan H, Lane MD.1995 Regulated expression of the obese gene product(leptin) in white adipose tissue and 3T3-L1 adipocytes.Proc Natl Acad SciUs A.92:9034-9037.

4.""Rentsch J, Chiesi M.1996 Regulation of ob gene mRNA levels in cultured adipocytes. FEBS Lett.379:55-59.

5. Wabitsch M, Jensen PB, Blum WF, et al. 1996 Insulin and cortsol promote leptin production in culturedhuman fat cells.Diabetes.45:1435-1438.

6. Stephens TW,Basinski M, Bristow PK, et al.1995 The role of neuropeptide Y in the antiobesity actioof the obese gene product. Nature.377:530-532.

7.Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P.1995 Recombinant mouse OB protein: evidencefor a peripheral signal linking adiposity and central neural networks.Science. 269:546-549.

8. Pelleymounter MA, Cullen MJ,Baker MB, et al. 1995 Effects of the obese gene product on body weightregulation in oblob mice. Science. 269:540-543.

9. Levin N, Nelson C, Gurney A, Vandlen R, de-Sauvage F.1996 Decreased food intake does not

completely account for adiposity reduction after ob protein infusion.Proc Natl Acad Sci usA. 93:1726-1730.

10. Tartaglia LA, Dembski M, Weng X, et al. 1995 ldentfication and expression cloning of a leptin receptor,OB-R.Cell.83:1263-1271.

11. Chen H, Charlat O,Tartaglia LA, et al.1996 Evidence that the diabetes gene encodes the leptinreceptor: identification of a mutation in the leptin receptor gene in dbldb mice. Cell.84:491-495.

12. Lee GH, Proenca R, Montez JM, et al.1996 Abnormal splicing of theleptin receptor in diabetic mice.Nature.379:632-635.

13.Lynn RB, Cao GY, Considine RV, Hyde TM, Caro JF.1996 Autoradiographic localization of leptin binding inthe choroid plexus of oblob and db/db mice. Biochem Biophys Res Commun.219:884-889.

14. Considine RV,Considine EL, Wiliams CJ, Hyde TM, caro JF.1996 The hypothalamic leptin receptor inhumans: identification of incidental sequence polymorphisms and absence of the dbldb mouse and fa/fa rat mutations.Diabetes.45:992-994.

15.Sinha MK,Opentanova l, Ohannesian JP, et al.1996 Evidence of free and bound leptin in humancirculation.J Clin Invest.98:1277-1282.

16. Ahima RS,Prabakaran D, Mantzoros C, et al.1996 Role of leptin in the neuroendocrine response tofasting. Nature.382:250-252.

17. Chehab FF, Lim ME, Lu R.1996 Correction of the sterility defect in homozygous obese female mice bytreatment with the human recombinant leptin.Nat Genet.12:318-320.

18. Schwartz MW,Baskin DG, BukowskiTR, et al.1996 Specificity of leptin action on elevated bloodglucose levels and hypothalamic neuropeptide Y gene expression in oblob mice. Diabetes.45:531-535.

19. Schwartz MW, Seeley RJ,Campflield LA, Burn P, Baskin DG. 1996 ldentification of targets of leptin action inrat hypothalamus.J Clin Invest. 98:1101-1106.

20. Campfield LA, Smith FJ,Burn P.1996 The OB protein (leptin) pathway - a link between adipose tissuemass and central neural networks. Horm metab Res.28:619-632.

21. Rohner-JeanrenaudF, Cusin l, Sainsbury A,Zakrzewska KE,Jeanrenaud B.1996 The loop systembetween neuropeptide Y and leptin in normal and obese rodents. Horm metab Res.28:642-648.

22. Chan YY, steiner RA, Clifton DK.1996 Regulation of hypothalamic neuropeptide-Y neurons by growthhormone in the rat.Endocrinol.137:1319-1325.

23. Pierroz DD, Catzeflis C, Aebi AC,Rivier JE, Aubert ML.1996 Chronic administration of neuropeptide Yinto the lateralyentricle inhibits both the pituitary-testicular axis and growth hormone and insulin-like growthfactor I secretion in intact adult male rats.Endocrinol.137:3-12.

24.Frederich RC,Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS.1995 Leptin levels reflect bodylipid content in mice: evidence for diet-induced resistance to leptin action.Nat Med.1:1311-1314.

25. S Maffei M, Halaas J, Ravussin E, et al. 1995 Leptin levels in human and rodent: measurement of plasmaleptin and ob RNA in obese and weight-reduced subjects. Nat Med.1:1155-1161.

26. Considine RV,Sinha MK,Heiman ML, et al. 1996 Serum immunoreactive-leptin concentrations innormal-weight and obese humans. N Engl J Med.334:292-295.

27. Kolaczynski JW, Considine RV, Ohannesian J, et al.1996 Responses of leptin to short-term fasting andrefeeding in humans: A link with keto-genesis but not ketones themselves. Diabetes.45:1511-1515.

28. Harris RB， Ramsay TG, Smith SR, Bruch RC. 1996 Early and late stimulation of ob mRNA expression inmeal-fed and overfed rats.J Clin Invest.97:2020-2026.

29. Kolaczynski JW,Ohannesian J,Considine RV, Marco C,Caro JF.1996 Response of leptin toshort-term and prolonged overfeeding in humans.J Clin Endocrinol metab.91:4162-4165.

30. Saladin R, De-Vos P, Guerre-Millo M, et al. 1995 Transient increase in obese gene expression afterfood intake or insulin administration. Nature.377:527-529.

31. Cusin l, Sainsbury A, Doyle P, Rohner-Jeanrenaud F,Jeanrenaud B.1995 The ob gene and insulin.Arelationship leading to clues to the understanding of obesity.Diabetes.44:1467-1470.

32. Kolaczynski JW, Nyce MR, Considine RV, et al. 1996 Acute and chronic effects of insulin on leptinproduction in humans: studies in vivo and in vitro. Diabetes.45:699-701.

33. Malstrom R, Taskinen M-R, Karonen S-L, YKi-Jarvinen H. 1996 Insulin increases plasma leptinconcentrations in normal subjects and patients with NIDDM. Diabetologia. 39:993-996.

34. De-Vos P,Saladin R, Auwerx J, Staels B. 1995 Induction of ob gene expression by corticosteroids isaccompanied by body weight loss and reduced food intake.J Biol Chem.270:15958-15961.

35.`Slieker LJ, Sloop kW,Surface PL, et al.1996 Regulation of expression of ob mRNA and protein byglucocorticoids and cAMP.J Biol Chem. 271:5301-5304.

36. Miell JP, Englaro P, Blum WF.1996 Dexamethasone induces an acute and sustained rise in circulatingleptin levels in normal human subjects.Horm metab Res. 28:704-707.

37.Sinha MK, Ohannesian JP, Heiman ML, et al.1996 Nocturnal rise of leptin in lean, obese, andnon-insulin- dependent diabetes mellitus subjects.J Clin Invest.97:1344-1347.

38. Havel PJ , Kasim-Karakas S, Dubuc GR, Mueller W, Phinney SD.1996 Gender difference in plasmaleptin concentrations. Nature Med.2:949-950.

39. Rosenbaum M, Nicolson M, Hirsch J, et al.1996 Effects of gender, body composition, and menopauseon plasma concentrations of leptin.J Clin Endocrinol metab.81:3424-3427.

40. Hassink SG, Sheslow Dv, de Lancey E, Opentanova l, Considine RV,Caro JF 1996 Serum jeptin inchildren with obesity: relationship to gender and development.Pediatrics.98:201-203.

41. Scholz GH, Englaro P, Thiele l, et al.,1996 Dissociation of serum leptin concentration and body fatcontent during long term dietary intervention in obese individuals.Horm metab Res.28:718-723.

42.Caro JF, Kolaczynski Jjw,Nyce MR, et al. 1996 Decreased cerebrospinal-fluid/serum leptin ratio inobesity: a possible mechanism for leptin resistance.Lancet.348:159-161.

43. Robinson CJ,Gaines-Das R,Woollacott D, et al.2001 The first international standard for human leptinand the first international standard for mouse leptin: comparison of candidate preparations by in vitro bioassaysand immunoassays.J Molecular Endocrinol. 27:69-76.

44. Adresse NIBSC: Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3Qc,Great Britain.

45. Blum WF, Juul A; Reference ranges of serum leptin,s.318-326. In:Leptin -the voice of adipose tissue,Blum WF et al, eds., Johann Ambrosius Verlag, Heidelberg, 1997.

• 试剂卡孵育器
• 检测试剂
• 免疫分析仪
• 免疫层析分析仪
• 免疫定量分析仪
• 免疫荧光分析仪
• 免疫分析仪
• 检测试剂盒